What does a low LDL/HDL ratio indicate?

A low LDL/HDL ratio (below 2.5) indicates excellent cardiovascular health and reduced heart disease risk. This favorable ratio means you have low levels of harmful LDL cholesterol relative to protective HDL cholesterol.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

When it comes to understanding your cardiovascular health, cholesterol numbers tell an important story. While many people focus on total cholesterol or individual LDL and HDL values, the ratio between these two types of cholesterol provides one of the most meaningful insights into your heart disease risk. A low LDL/HDL ratio is generally excellent news for your cardiovascular system, but understanding what this means and how to maintain it requires diving deeper into the science of cholesterol metabolism.

The LDL/HDL ratio compares your levels of low-density lipoprotein (LDL) cholesterol, often called "bad" cholesterol, to high-density lipoprotein (HDL) cholesterol, known as "good" cholesterol. This ratio offers a more nuanced view of cardiovascular risk than looking at either number in isolation, as it reflects the balance between cholesterol that can accumulate in your arteries and cholesterol that helps remove it.

Understanding the LDL/HDL Ratio

The LDL/HDL ratio is calculated by dividing your LDL cholesterol level by your HDL cholesterol level. For example, if your LDL is 100 mg/dL and your HDL is 50 mg/dL, your ratio would be 2.0. This simple calculation provides valuable insight into how well your body manages cholesterol transport and removal.

LDL cholesterol earned its "bad" reputation because it transports cholesterol from the liver to tissues throughout your body. When LDL levels are too high, excess cholesterol can deposit in artery walls, forming plaques that narrow blood vessels and increase heart disease risk. HDL cholesterol, conversely, acts as a cardiovascular custodian, collecting excess cholesterol from tissues and artery walls and returning it to the liver for disposal.

Understanding your cholesterol ratios and overall lipid profile is crucial for preventing cardiovascular disease. Regular monitoring through comprehensive testing can help you track changes over time and assess the effectiveness of lifestyle modifications or treatments.

Optimal Ratio Ranges

Medical professionals generally consider an LDL/HDL ratio below 2.5 to be optimal for cardiovascular health. Here's how different ratio ranges are typically interpreted:

  • Below 2.0: Excellent - Very low cardiovascular risk
  • 2.0-2.5: Optimal - Low cardiovascular risk
  • 2.5-3.5: Borderline - Moderate cardiovascular risk
  • 3.5-5.0: Poor - High cardiovascular risk
  • Above 5.0: Very Poor - Very high cardiovascular risk

A low ratio indicates that you have relatively more protective HDL cholesterol compared to potentially harmful LDL cholesterol. This favorable balance suggests your cardiovascular system has robust mechanisms for removing excess cholesterol and preventing arterial plaque formation.

What a Low LDL/HDL Ratio Means for Your Health

A low LDL/HDL ratio is one of the strongest indicators of cardiovascular health. Research consistently shows that individuals with lower ratios have significantly reduced risks of heart attack, stroke, and other cardiovascular events. This protective effect stems from the favorable balance between cholesterol delivery and removal in your bloodstream.

Beyond cardiovascular benefits, a low LDL/HDL ratio often correlates with other positive health markers. People with favorable ratios typically have better insulin sensitivity, lower inflammation levels, and healthier blood pressure. These interconnected benefits create a positive feedback loop that supports overall metabolic health.

Cardiovascular Protection

The protective effects of a low LDL/HDL ratio extend throughout your cardiovascular system. High HDL levels actively work to prevent atherosclerosis by removing cholesterol from arterial walls before it can form dangerous plaques. This process, called reverse cholesterol transport, becomes more efficient when HDL levels are high relative to LDL.

Additionally, HDL cholesterol possesses anti-inflammatory and antioxidant properties that further protect blood vessels. These particles help prevent LDL oxidation, a key step in plaque formation, and reduce inflammation in arterial walls. The combination of cholesterol removal and vessel protection makes a low LDL/HDL ratio particularly valuable for long-term cardiovascular health.

Metabolic Health Benefits

A favorable LDL/HDL ratio often indicates broader metabolic health. Research shows strong associations between healthy cholesterol ratios and improved glucose metabolism, reduced insulin resistance, and lower risks of metabolic syndrome. These connections highlight how cardiovascular and metabolic health are deeply intertwined.

People with low LDL/HDL ratios also tend to have healthier body compositions, with less visceral fat and better muscle mass retention. This relationship is bidirectional: maintaining a healthy weight and body composition helps improve cholesterol ratios, while favorable ratios support metabolic processes that make weight management easier.

Factors That Influence Your LDL/HDL Ratio

Your LDL/HDL ratio results from a complex interplay of genetic, lifestyle, and environmental factors. While genetics play a role in determining your baseline cholesterol metabolism, lifestyle factors often have the most significant impact on your ratio and can override genetic predispositions in many cases.

Genetic Factors

Genetic variations influence how your body produces, transports, and clears cholesterol. Some people inherit genes that naturally promote higher HDL production or more efficient LDL clearance, leading to favorable ratios without much effort. Others may have genetic variants that predispose them to higher LDL or lower HDL levels.

Familial hypercholesterolemia, a genetic condition affecting about 1 in 250 people, causes very high LDL levels and unfavorable ratios from birth. However, even with genetic predispositions, lifestyle modifications can significantly improve cholesterol ratios and reduce cardiovascular risk.

Lifestyle Factors

Diet profoundly impacts your LDL/HDL ratio. Consuming trans fats and excessive saturated fats raises LDL while lowering HDL, creating an unfavorable ratio. Conversely, eating unsaturated fats from sources like olive oil, nuts, and fatty fish can lower LDL and raise HDL. Soluble fiber from oats, beans, and vegetables also helps reduce LDL absorption.

Physical activity is one of the most effective ways to improve your ratio. Regular aerobic exercise can increase HDL levels by 5-10% while modestly reducing LDL. Resistance training also contributes to favorable changes in cholesterol metabolism. The combination of cardiovascular and strength training provides optimal benefits for cholesterol management.

For those looking to optimize their cholesterol ratios and overall cardiovascular health, regular monitoring of advanced lipid markers provides valuable insights beyond standard cholesterol tests.

How to Maintain or Achieve a Low LDL/HDL Ratio

Achieving and maintaining a low LDL/HDL ratio requires a comprehensive approach that addresses diet, exercise, stress management, and other lifestyle factors. The good news is that many of the same strategies that improve your ratio also enhance overall health and well-being.

Dietary Strategies

Focus on incorporating heart-healthy fats into your diet. Replace saturated fats with monounsaturated fats from olive oil, avocados, and nuts. Include omega-3 fatty acids from fatty fish like salmon, mackerel, and sardines at least twice weekly. These dietary fats can help raise HDL while lowering LDL and triglycerides.

Increase your intake of soluble fiber, aiming for 25-35 grams of total fiber daily. Soluble fiber binds to cholesterol in your digestive system, preventing its absorption. Excellent sources include oatmeal, barley, beans, lentils, apples, and Brussels sprouts. Plant sterols and stanols, found in fortified foods or supplements, can also help block cholesterol absorption.

  • Limit refined carbohydrates and added sugars, which can lower HDL and raise triglycerides
  • Choose whole grains over processed grains
  • Include plenty of colorful fruits and vegetables for their antioxidant benefits
  • Consider adding soy protein, which may modestly improve cholesterol ratios
  • Moderate alcohol consumption, as small amounts may raise HDL (though this must be balanced against other health risks)

Exercise Recommendations

Aim for at least 150 minutes of moderate-intensity aerobic exercise or 75 minutes of vigorous exercise weekly. Activities like brisk walking, jogging, cycling, and swimming effectively improve cholesterol ratios. High-intensity interval training (HIIT) may provide particularly robust benefits for HDL levels.

Include resistance training at least twice weekly. Building muscle mass improves overall metabolic health and can positively influence cholesterol metabolism. Even modest strength gains can contribute to better LDL/HDL ratios over time.

When to Be Concerned About Your Cholesterol Ratio

While a low LDL/HDL ratio is generally positive, it's important to consider this metric within the context of your overall lipid profile and health status. In rare cases, extremely low LDL levels (below 40 mg/dL) may indicate underlying health issues or nutritional deficiencies, though this is uncommon.

More commonly, people need to be concerned when their ratio begins to climb above 2.5, especially if this change occurs rapidly. Factors that can worsen your ratio include weight gain, reduced physical activity, dietary changes, certain medications, and hormonal shifts such as menopause.

Regular monitoring helps you catch unfavorable changes early. Consider getting your cholesterol checked annually if you have a low ratio and no risk factors, or more frequently if you have a family history of heart disease, diabetes, or other cardiovascular risk factors. Advanced lipid testing that includes particle size and number can provide even more detailed insights into your cardiovascular risk.

The Role of Advanced Lipid Testing

While the LDL/HDL ratio provides valuable information, advanced lipid testing offers deeper insights into cardiovascular risk. Tests measuring apolipoprotein B (ApoB) and apolipoprotein A1 (ApoA1) can provide more accurate risk assessment than standard cholesterol measurements alone.

ApoB represents the number of potentially atherogenic particles in your blood, as each LDL particle contains one ApoB protein. ApoA1 is the main protein component of HDL particles. The ApoB/ApoA1 ratio may predict cardiovascular risk even more accurately than the LDL/HDL ratio, especially in people with diabetes or metabolic syndrome.

Particle size and number also matter. Small, dense LDL particles are more atherogenic than large, buoyant ones. Similarly, large HDL particles may be more protective than small ones. Advanced testing can reveal these nuances and guide more personalized treatment approaches.

Tracking Your Progress Over Time

Maintaining a low LDL/HDL ratio is a long-term commitment that requires consistent monitoring and adjustment. Your cholesterol levels can fluctuate based on seasonal changes, stress levels, dietary variations, and other factors. Regular testing helps you understand these patterns and make informed decisions about your health.

When making lifestyle changes to improve your ratio, allow at least 6-8 weeks before retesting to see the full effects. Keep a log of your results along with notes about your diet, exercise, and other relevant factors. This information helps you and your healthcare provider identify what strategies work best for your unique physiology.

Remember that improving your LDL/HDL ratio is just one aspect of cardiovascular health. Continue to monitor other important markers like blood pressure, blood sugar, and inflammatory markers for a comprehensive view of your heart disease risk. The combination of a low LDL/HDL ratio with other favorable health metrics provides the strongest protection against cardiovascular disease.

References

  1. Millán J, Pintó X, Muñoz A, et al. Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757-765.[PubMed]
  2. Calling S, Johansson SE, Wolff M, Sundquist J, Sundquist K. The ratio of total cholesterol to high density lipoprotein cholesterol and myocardial infarction in Women's health in the Lund area (WHILA): a 17-year follow-up cohort study. BMC Cardiovasc Disord. 2019;19(1):239.[PubMed][DOI]
  3. Arsenault BJ, Rana JS, Stroes ES, et al. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol. 2009;55(1):35-41.[PubMed][DOI]
  4. Fernández-Macías JC, Ochoa-Martínez AC, Varela-Silva JA, Pérez-Maldonado IN. Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses. Arch Med Res. 2019;50(5):285-294.[PubMed][DOI]
  5. Mann S, Beedie C, Jimenez A. Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Med. 2014;44(2):211-221.[PubMed][DOI]
  6. Soliman GA. Dietary Fiber, Atherosclerosis, and Cardiovascular Disease. Nutrients. 2019;11(5):1155.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my LDL/HDL ratio at home?

You can test your LDL/HDL ratio at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive cholesterol testing including LDL, HDL, total cholesterol, and advanced markers like ApoB and ApoA1. The program provides CLIA-certified lab results from a simple at-home blood draw.

What is considered a dangerously low LDL/HDL ratio?

While low ratios are generally beneficial, ratios below 1.0 are rare and may warrant investigation. Extremely low LDL levels (below 40 mg/dL) combined with normal HDL could indicate malnutrition, hyperthyroidism, or certain genetic conditions. Always discuss unusual results with your healthcare provider.

How quickly can I improve my LDL/HDL ratio?

With consistent lifestyle changes, you can see improvements in your LDL/HDL ratio within 6-8 weeks. HDL levels typically respond more slowly than LDL, sometimes taking 2-3 months to show significant changes. Dietary modifications often produce faster results than exercise alone, though combining both provides optimal benefits.

Is the LDL/HDL ratio more important than total cholesterol?

Yes, the LDL/HDL ratio is generally more predictive of cardiovascular risk than total cholesterol alone. Total cholesterol includes both protective HDL and harmful LDL, so a high total could actually indicate high HDL levels. The ratio provides better insight into the balance between cholesterol removal and accumulation.

Can medications affect my LDL/HDL ratio?

Yes, several medications can impact your ratio. Statins primarily lower LDL but may slightly raise HDL. Niacin and fibrates can significantly raise HDL while lowering LDL. Some medications like beta-blockers or diuretics may adversely affect the ratio. Always discuss medication effects with your healthcare provider.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details